Lelaidier 1994.

Methods	RCT.
Participants	Setting: not clear. 32 women. Inclusion criteria: women who had a previous CS with gestational age > 38 and < 42 weeks confirmed by ultrasound. All women were scheduled for induction (21 for "post‐dates", 7 for hypertension and 4 for FGR); Bishop score < 4.
Interventions	The study was carried out over a 4 day observation period, induction was planned for the fourth day (PGE₂ and amniotomy or oxytocin induction if Bishop score > 3). Women attended the outpatient's department for NST daily. Intervention group: 200 mg oral mifepristone on days 1 and 2. Comparison group: placebo, same regime as intervention group.
Outcomes	CS, assisted birth, uterine scar separation, fetal distress.
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Described as "randomisation list" using block design (block size 4).
Allocation concealment (selection bias)	Low risk	Coded drug boxes.
Blinding (performance bias and detection bias) Women	Low risk	Described as double‐blind placebo controlled study. "External appearance of the tablets was similar."
Blinding (performance bias and detection bias) Clinical staff	Low risk	Intervention and placebo tablet described as similar.
Blinding (performance bias and detection bias) Outcome assessor	Unclear risk	Blinding of outcome assessors not described.
Incomplete outcome data (attrition bias) All outcomes	Low risk	All women appeared to be accounted for in the analysis.
Selective reporting (reporting bias)	Unclear risk	Outcomes not stated in methods text
Other bias	Unclear risk	Baseline characteristics similar but no formal test (P value) reported.